BONDMOXACIN

This brand name is authorized in Nigeria.

Active ingredients

The drug BONDMOXACIN contains one active pharmaceutical ingredient (API):

1	Moxifloxacin UNII C53598599T - MOXIFLOXACIN HYDROCHLORIDE
	Moxifloxacin, a fourth-generation fluoroquinolone, has in vitro activity against a wide range of Gram-positive and Gram-negative pathogens. The bactericidal action of moxifloxacin results from the inhibition of both type II topoisomerases (DNA gyrase and topoisomerase IV) required for bacterial DNA replication, transcription and repair.
	Read more about Moxifloxacin

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-1641	Eye drops	BONDMOXACIN EYE DROP SOL_DROPS 5 mg/5 mL	BONDMOXACIN EYE DROP B4-1641 BONDMOXACIN EYE DROP Active Ingredient- 5.45 mg moxifloxacin hydrochloride, equivalent to 5 mg moxifloxacin base. Excipient- Benzalkonium Chloride Solution BP- 0.01% and purified water Eye Drops Prescription Only Medicine (POM) BOND CHEMICAL INDUSTRIES LIMITED, ASALU INDUSTRIAL ESTATE AWE. AWE OYO Nigeria DIVINE LABORATORIES PVT. LTD., BLOCK NO. 471, DABHASA, TALUKA PADRA, DIST. VADODARA- 391 440, GUJARAT, INDIA., India 1/26/2023 1/25/2028	26/01/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
S01AE07		S Sensory organs → S01 Ophthalmologicals → S01A Antiinfectives → S01AE Fluoroquinolones
Discover more medicines within S01AE07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-1641